Oral 5-alpha-reductase inhibitors do not increase the risk for cardiovascular disease in patients treated for androgenetic ...

Families may be more motivated to participate in a pediatric weight management program when children and adolescents ...

The FDA has cleared Tandem’s Control-IQ technology as the first ever AID specifically for use in pregnancies complicated by ...

Sleep aids, including melatonin, are commonly used in children and adolescents, yet few studies have examined family- and ...

A remote culinary medicine program combining cooking and health coaching leads to an average weight loss of more than 4% at 1 ...

Patients with HIV infection who receive a liver transplant may face a similar risk of developing new cancers as those without ...

Researchers conducted a retrospective cross-sectional analysis of patients diagnosed with de novo metastatic breast cancer to evaluate presentation and treatment differences across three main subtypes ...

Patients with chronic kidney disease are often taken off RAS inhibitors after declines in kidney function, but the risks may ...

Intraoperative reirradiation in combination with a second breast-conserving surgery is safe and well tolerated in patients ...

There was a study published from Sweden in which they looked at the different subtypes of type 2 diabetes in a population ...

European regulators have recommended expanding use of the IL-23 inhibitor Skyrizi to treat moderate-to-severe plaque psoriasis in children aged 6 years or older who require systemic therapy.

A small Italian study suggests a way to safely reduce gastrectomy rates in microsatellite instability-high disease.